Development and Characterization of an Animal Model of Severe Pulmonary Arterial Hypertension

作者：Morimatsu Yoshitaka; Sakashita Naomi; Komohara Yoshihiro; Ohnishi Koji; Masuda Hiroshi; Dahan Diana; Takeya Motohiro; Guibert Christelle^*; Marthan Roger

来源：Journal of Vascular Research, 2012, 49(1): 33-42.

DOI：10.1159/000329594

• Pulmonary hypertension
• Pulmonary vascular remodeling
• Monocrotaline
• Hypobaric chronic hypoxia
• Medial hypertrophy

Pulmonary arterial hypertension (PAH) is a serious pathological phenomenon with poor prognosis, which is associated with morphological as well as hemodynamic alteration of the pulmonary circulation. To establish an animal model mimicking severe human PAH, we combined 2 well-described procedures, i.e. exposure to hypobaric chronic hypoxia and administration of monocrotaline hydrochloride in rats. Compared to a single procedure, the combined procedure induced more severe right ventricle hypertrophy and an increase in right ventricle systolic pressure. Histological examination on the combined procedure model revealed a severe medial hypertrophy as well as occlusive vascular changes of the intra-acinar pulmonary arteries with endothelial lesions. It is noteworthy that severe alterations including concentric neointimal thickening, abnormal endothelial proliferation, plexiform lesions and vascular occlusion with fibrin thrombi were observed in the combined pulmonary hypertension model when exposed to a long period of hypoxia. The present data indicate that a combined treatment of monocrotaline injection and hypobaric chronic hypoxia exposure produces more severe hemodynamic changes and histological alterations. Since human PAH diagnosed in clinical practice is often severe, this combined treatment animal model could be useful to identify relevant therapeutic targets acting on both hemodynamic and structural alterations of the pulmonary circulation.

• 出版日期2012